Veralto Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VLTO research report →
Range $106 – $135
Price Chart
About the company
Veralto Corporation is a global provider specializing in critical solutions across water quality management, brand protection, and packaging aesthetics. Its operations are structured into two primary divisions: Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment delivers advanced instrumentation and treatment technologies designed for the precise measurement, analysis, and purification of water.
- CEO
- Jennifer L. Honeycutt
- IPO
- 2023
- Employees
- 17,000
- HQ
- Waltham, MA, US
Get TickerSpark's AI analysis on VLTO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $28.36B
- P/E
- 28.96
- Fwd P/E
- 26.10
- PEG
- 2.73
- P/S
- 4.94
- P/B
- 8.89
- EV/EBITDA
- 21.72
- Div Yield
- 0.44%
- Gross Margin
- 60.20%
- Op Margin
- 21.84%
- Net Margin
- 17.27%
- ROE
- 32.22%
- ROIC
- 15.80%
Latest fiscal year · YoY change
- Revenue
- $5.50B+6.0%
- Gross Profit
- $3.30B+6.2%
- Op Income
- $1.28B
- Net Income
- $940.00M+12.8%
- EPS
- $3.79+12.5%
- OCF Growth
- +23.1%
- FCF Growth
- +23.7%
- 52W High
- $120.35
- 52W Low
- $80.03
- 50D MA
- $103.86
- 200D MA
- $94.21
- Beta
- 0.78
- RSI (14)
- 65
- Avg Volume
- 1.84M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Veralto delivered strong Q3 results with double-digit EPS growth, healthy demand across both segments, and a raised full-year EPS outlook backed by cost savings and disciplined capital deployment.· October 30, 2026
- Q3 total sales rose 7.5% year over year, adjusted EPS increased 19.2%, and free cash flow was $304 million.
- Core sales grew 5.1%, led by Water Quality at 6.4% and PQI at 3.2%; management said both segments accelerated sequentially from Q2 to Q3.
- Full-year adjusted EPS guidance was raised to $4.49-$4.52 per share, implying 15%-16% growth over the prior year.
- Q4 outlook calls for core sales growth of 5.5%-6.5%, about 5% growth from acquisitions, and total sales growth of approximately 10%-11%.
- Management said year-to-date capital deployment exceeded $1.65 billion across four bolt-on acquisitions and repurchases of 2.4% of outstanding shares.
Veralto reported Q3 2026 total sales growth of 7.5% year over year, adjusted EPS growth of 19.2%, free cash flow of $304 million, and core sales growth of 5.1%. Within core sales, Water Quality grew 6.4% and PQI grew 3.2%, with both segments accelerating sequentially from Q2 to Q3. For Q4, management expects core sales growth of 5.5%-6.5%, approximately 5% growth from acquisitions, and total sales growth of approximately 10%-11%. Full-year adjusted EPS guidance was raised to $4.49-$4.52 per share, representing 15%-16% growth over the prior year.
Jennifer Honeycutt emphasized that the quarter reflected strong execution, healthy demand, and the benefit of Veralto’s portfolio mix, with about 60% of revenue recurring. She highlighted secular demand drivers in water and packaging, including recycling/reclaim, water scarcity, data centers, food safety reformulation, and digital workflow adoption. Her tone was confident and upbeat, and she repeatedly pointed to the company’s third anniversary as an independent public company as evidence that the strategy is working.
Sameer Ralhan focused on guidance, margin cadence, and capital allocation. He said the Cost Optimization Program is on track, with $10 million-$15 million of savings expected in 2026, roughly half of the savings by the end of 2027, and the full run rate in 2028; he also noted about $35 million of cost saves at run rate and that Q4 margin fall-through should be 30%-35%, or about 30 basis points of year-over-year margin expansion, plus roughly 40 basis points from cost optimization, mostly offset by Cleanwater1 dilution. On capital allocation, he said Veralto has used about $550 million of the $750 million buyback authorization and remains active on M&A, with the pipeline still described as healthy.
Analysts focused on visibility into 2027, margin expansion, the durability of Water Quality demand, and whether PQI’s acceleration was real or partly driven by timing and easy comps. Management said Water Quality remains heavily recurring and largely insulated from federal funding swings, while PQI is benefiting from strong bookings in digital workflow solutions, steady marking-and-coding demand, and a recovery in color measurement instruments. On margins, management pointed to inflation, tariffs rolling off next year, and Cleanwater1 dilution as offsets to cost savings, saying more detail would come with the 2027 guidance in February.
The call suggested durable demand across both businesses, with recurring revenue, installed-base upgrades, and secular end-market growth supporting visibility. Veralto also appears to be executing well on M&A and integration, with management saying synergies at In-Situ and AQUAFIDES are ahead of plan and that Cleanwater1 expands exposure to faster-growing water treatment applications.
Management acknowledged timing volatility in some project-based businesses, especially packaging and color hardware and some water-side projects, though it said there were no indefinite delays or cancellations. The company also flagged 2027 margin headwinds from the loss of tariff benefit and dilution from Cleanwater1, even as cost savings ramp, leaving the next year’s margin path still to be fully laid out.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.8%
- Shares Outstanding
- 243.14M
- Float Shares
- 242.60M
of shares held by institutions
1,003 13F filers
Buy/sell ratio 0.39. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for VLTO, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Kevin HernHouse · OK01 | Sell | Aug 21, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Aug 14, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Aug 10, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Jun 24, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | May 11, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | May 1, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Apr 6, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Apr 13, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Jan 28, 26 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jan 29, 26 | Filing → |
| Greg LandsmanHouse · OH01 | Sell | May 29, 24 | Filing → |
| Markwayne MullinSenate · OK | Sell | Dec 5, 23 | Filing → |
| Sheldon WhitehouseSenate · RI | Sell | Nov 29, 23 | Filing → |
| Sheldon WhitehouseSenate · RI | Sell | Nov 29, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 29.96M | ▼ 1.10M |
| Blackrock, Inc. | 21.08M | ▼ 1.56M |
| T. Rowe Price Investment Management, Inc. | 17.51M | ▲ 3.79M |
| Vanguard Capital Management LLC | 15.96M | ▼ 82.27K |
| Vanguard Portfolio Management LLC | 12.11M | ▼ 39.31K |
| State Street Corp | 11.20M | ▲ 65.08K |
| First Trust Advisors LP | 8.73M | ▲ 537.99K |
| Geode Capital Management, LLC | 7.48M | ▲ 93.48K |
| Impax Asset Management Group PLC | 5.14M | ▼ 46.85K |
| Invesco Ltd. | 5.05M | ▼ 487.64K |
| Amundi | 4.18M | ▲ 651.63K |
| Alliancebernstein L.P. | 3.78M | ▲ 48.01K |
Held by 1,989 ETFs
Biggest fund positions in VLTO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 16, 26 | Ralhan Sameer | other | 3,833 |
| Nov 16, 26 | Skeete Bernard M | other | 93 |
| Nov 12, 26 | Wallis-Lage Cindy L. | other | 63 |
| Nov 12, 26 | Williams Thomas | other | 300 |
| Nov 12, 26 | MITTS HEATH A | other | 252 |
| Nov 10, 26 | Kapity Melissa | other | 5,146 |
| Nov 10, 26 | Kapity Melissa | sell | 5,146 |
| Nov 10, 26 | Kapity Melissa | other | 5,146 |
| Nov 3, 26 | Bystrom Mattias | other | 9,069 |
| Nov 3, 26 | Bystrom Mattias | sell | 1,802 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VLTO coverage
Recent articles, reports, and earnings notes.
No research on VLTO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VLTO report →Veralto's Q3 Margin Expands 170 Bps: Can VLTO Maintain Gains?
zacks.com · Nov 20
3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
marketbeat.com · Nov 17
12,014 Veralto Corporation $VLTO Shares Sold by CenterBook Partners LP
defenseworld.net · Nov 13
Reasons Why Investors Can Consider Buying Veralto Stock Now
zacks.com · Nov 12
Veralto Corporation $VLTO Stake Cut by Boston Trust Walden Corp
defenseworld.net · Nov 5
Associated Banc Corp Makes New Investment in Veralto Corporation $VLTO
defenseworld.net · Nov 5
Veralto's Q3 Earnings Beat Estimates on Strong Sales & Margins
zacks.com · Nov 2
What Veralto (VLTO) Said on Its Q3 Earnings Call
marketbeat.com · Oct 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.